Psoriasis is a systemic, immunologic, genetic disease that manifests in the skin and/or joints of affected individuals. Approximately 1.5 million US adults have moderate to severe disease, which is usually difficult to treat and requires intensive treatment. Psoriasis is associated with a number of comorbidities, including psoriatic arthritis, cardiovascular disease, and Crohn’s disease, and can have a significant negative impact on quality of life. Although treatment options for psoriasis have expanded in recent years, the disease is still often undertreated, leading to increased morbidity. In this activity, expert faculty will discuss strategies for the management of moderate to severe psoriasis, including treating to target and the use of the most recent therapies. Strategies for the long-term management of patients via a multidisciplinary team will also be discussed.
Audio-enhanced slide lecture
To update clinicians on current strategies for the management of moderate to severe psoriasis, including the use of novel therapies, identification and management of comorbidities and side effects, and the implementation of a multidisciplinary, collaborative care strategy
- Apply standards for the differential diagnosis and classification of psoriasis to prompt a timely referral and initiation of therapy
- Assess available options for the treatment of moderate to severe psoriasis based on efficacy and safety data
- Implement multidisciplinary, patient-centered strategies for long-term management of moderate to severe psoriasis
Nurse practitioners and physician assistants
In support of improving patient care, this activity has been planned and implemented by Continuing Education Alliance and the American Academy of PAs (AAPA). Continuing Education Alliance is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Nursing contact hours: 1.00, which includes 0.75 hours of pharmacology credit
This program has been reviewed and is approved for a maximum of 1.00 AAPA Category 1 CME credits by the AAPA Review Panel. Approval is valid for one year from the issue date of August 22, 2017. Participants may submit the post-test at any time during that period.
This program was planned in accordance with AAPA CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs.
This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Continuing Education Alliance, Practicing Clinicians Exchange, the AAPA, or Lilly.
All faculty and planners participating in continuing education activities sponsored by Continuing Education Alliance are expected to disclose to the audience any significant support or substantial relationships with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. In addition, all faculty are expected to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and planning committee have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr Bagel: consultant/investigator/speaker: AbbVie, Amgen, Celgene, Janssen, LEO, Lilly, Novartis.
Ms Aldredge: consultant/speaker: AbbVie, Celgene, Lilly, Novartis.
The Planning Committee for this activity included Ruth Cohen and Devera Pine of Continuing Education Alliance; and Mark Christiansen, PhD, PA-C, of the University of the Pacific. The members of the Planning Committee have no significant relationships to disclose.
Participants wishing to earn CE/CME credit must:
- Listen to the presentation and study the program slides
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form online
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 70%.
The estimated time to complete this activity is 1.00 hours.
Release date: August 22, 2017
Expiration date: August 22, 2018
© 2018 Practicing Clinicians Exchange. All Rights Reserved. LPCE92417